Articles by Rachel Rabinovitch, MD
104 Identification of Ductal Carcinoma In Situ Patients With Low-Risk Clinicopathology Who Benefit From Radiation Therapy With and Without Endocrine Therapy After Breast-Conserving Surgery Assessed With the 7-Gene Biosignature
ByPat W. Whitworth,Chirag Shah, MD,Frank Vicini, MD,Rachel Rabinovitch, MD,Julie A. Margenthaler, MD,Fredrik Warnberg,Micheal Leo,Sheila Weinmann,G. Bruce Mann,David J. Dabbs,Jess Savala,Steven C. Shivers,Karuna Mittal,Troy Bremer 
38 Comparing Risk Stratification and Radiotherapy Benefit for Patients With DCIS Using a 7-Gene Biosignature as Compared to a Clinicopathologic Nomogram
ByJulie A. Margenthaler, MD,Karuna Mittal,Frank A. Vicini, MD,Chirag Shah, MD,Rachel Rabinovitch, MD,Pat W. Whitworth,Brian Czerniecki,David J. Dabbs,G. Bruce Mann,Fredrik Wärnberg,Sheila Weinmann,Michael Leo,Steven C. Shivers,Troy Bremer 39 7-Gene Predictive Biosignature Improves Risk Stratification for Breast Ductal Carcinoma In Situ Patients Compared to Clinicopathologic Criteria, Identifying a Low-Risk Group Not Clinically Benefiting from Adjuvant Radiotherapy
ByRachel Rabinovitch, MD,Frank A. Vicini, MD,Chirag Shah, MD,Julie A. Margenthaler, MD,Brian Czerniecki,Pat W. Whitworth,David J. Dabbs,G. Bruce Mann,Fredrik Wärnberg,Sheila Weinmann,Michael Leo,Jess Savala,Steven C. Shivers,Karuna Mittal,Troy Bremer 40 Characterization of Recurrence Risk After Lumpectomy and Radiotherapy in HER2-Positive Ductal Carcinoma in Situ of the Breast Using a 7-Gene Predictive Biosignature: Implications for the NSABP-B43 Trial Results
ByFrank A. Vicini, MD,Chirag Shah, MD,Rachel Rabinovitch, MD,Pat W. Whitworth,Julie A. Margenthaler, MD,Brian Czerniecki,David J. Dabbs,Sheila Weinmann,Michael Leo,G. Bruce Mann,Fredrik Wärnberg,Jess Savala,Steven C. Shivers,Karuna Mittal,Troy Bremer 
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
BySteven C. Shivers,Pat W. Whitworth,Rachel Rabinovitch, MD,Frank Vicini, MD,Chirag Shah, MD,Fredrik Wärnberg,G. Bruce Mann,Karuna Mittal,Troy Bremer 38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
ByPat W. Whitworth,Rachel Rabinovitch, MD,Frank A. Vicini, MD,Chirag Shah, MD,Fredrik Wärnberg,G. Bruce Mann,Steven C. Shivers,Karuna Mittal,Troy Bremer 
Don’t Be Fooled by DCIS
ByRegina J. Brown, MD,Sharon Sams, MD, MPH,Dulcy E. Wolverton, MD,Tae Chong, MD,Virginia F. Borges, MD, MMSc,Rachel Rabinovitch, MD,Colleen D. Murphy, MD A 46-year-old woman had a routine screening mammogram that showed new calcifications in the posterior left breast. A diagnostic mammogram showed several small punctate calcifications, and a 6-month interval follow-up was recommended.
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies
ByLinda Overholser, MD, MPH,Elena Shagisultanova, MD, PhD,Rachel Rabinovitch, MD,Nicole Kounalakis, MD,Jennifer Diamond, MD,Christina A. Finlayson, MD,Christine M. Fisher, MD, MPH,Peter Kabos, MD,Anthony D. Elias, MD,Virginia F. Borges, MD, MMSc,Jose Mayordomo, MD, PhD We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma.
A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma
ByRegina J. Brown, MD,Colleen D. Murphy, MD,Gwen H. Lisella, MD,Arlene L. Libby, MD,Uchenna O. Njiaju, MD,Rachel Rabinovitch, MD,Virginia F. Borges, MD, MMSc A 40-year-old woman noted a large mass in her right breast. A diagnostic mammogram and ultrasound confirmed a 3.4-cm mass with associated microcalcifications.
Early-Stage BRCA2-Linked Breast Cancer Diagnosed in the First Trimester of Pregnancy Associated With a Hypercoagulable State
ByJennifer R. Diamond, MD,Christina A. Finlayson, MD,Christiane Thienelt, MD,Peter Kabos, MD,Laura Hardesty, MD,Linda Barbour, MD, MSPH,Catherine E. Klein, MD,Rachel Rabinovitch, MD,Anthony D. Elias, MD,Virginia F. Borges, MD, MMSc This feature examines the case of a patient with newly diagnosed breast cancer in the setting of a first-trimester pregnancy presenting to our multidisciplinary breast cancer clinic.
A Young Woman With a Small ER-Positive Breast Cancer, a Micrometastatic Axillary Lymph Node, and an Intermediate Oncotype DX Recurrence Score
ByDaniel W. Bowles, MD,Rachel Rabinovitch, MD,Virginia F. Borges, MD, MMSc,Alexander Urquhart, MD,Meenakshi Singh, MD,Christina A. Finlayson, MD,Anthony D. Elias, MD patient is a 39-year-old premenopausal woman who presents with a new diagnosis of breast cancer to our multidisciplinary second opinion clinic.
A Woman With Primary Breast Cancer and a Solitary Sternal Metastasis
ByAlexander Menter, MD,Alexander Urquhart, MD,Virginia F. Borges, MD, MMSc,Rachel Rabinovitch, MD,Meenakshi Singh, MD,William Robinson, MD, PhD,Paul Seligman, MD,Christina A. Finlayson, MD,Anthony D. Elias, MD The patient presented to her primary care physician 3 months prior with an inverted left nipple and a palpable lump that was highly suggestive of neoplasm on mammogram. An ultrasound-guided core biopsy revealed an infiltrating solid-type ductal carcinoma in situ. The estimated size of the mass was approximately 1 cm. She had no symptoms suggestive of metastatic disease.
Early-Stage BRCA2-Linked Breast Cancer Diagnosed in the First Trimester of Pregnancy Associated With a Hypercoagulable State
A Woman With Primary Breast Cancer and a Solitary Sternal Metastasis
A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma
Don’t Be Fooled by DCIS